Related by context. All words. (Click for frequent words.) 86 Society CTOS 75 Clinical Oncology Annual Meeting 74 Hematology Annual Meeting 73 Nephrology Renal Week 72 Hematology Meeting 72 Cancers Symposium 72 ICAAC IDSA 71 ASH Annual Meeting 71 Gastrointestinal Cancers Symposium 71 Hematology ASH Annual Meeting 71 Genitourinary Cancers Symposium 71 Clinical Oncology ASCO Annual 71 AACR San Antonio 70 Cell Biology ASCB 70 ASCO GI 70 AACR #st Annual Meeting 70 Biological Therapy 70 UEGW 69 Interventional Radiology SIR 69 st Annual Meeting 69 #st Annual Meeting 69 Cancer iSBTc 69 Clinical Oncology Gastrointestinal Cancers 69 Neuro Oncology SNO 69 ASGT 69 Transcatheter Cardiovascular Therapeutics TCT 69 Hematology ASH Meeting 68 Cardiology ESC Congress 68 Digestive Diseases Week 68 EORTC NCI 68 Medical Oncology ESMO 68 ASCO GU 68 Rheumatology ACR Annual 68 CTRC AACR San Antonio 68 Clinical Oncologists 67 ASCO Breast Cancer 67 Human Genetics ASHG 67 ASCO Annual Meeting 67 Hematology ASH 67 AACR NCI EORTC 67 AHA Scientific Sessions 67 Cellular Therapy ISCT 67 ECTRIMS 67 Oncology ASTRO 67 Surgical Oncology SSO 67 Therapeutics TCT 67 Radiation Oncology ASTRO 67 Breast Surgeons ASBS 67 Late Breaker 67 Gene Therapy ASGT 66 Endocrine Society ENDO 66 Clinical Oncology ASCO Gastrointestinal 66 Therapeutic Radiation 66 Digestive Disease Week DDW 66 Therapeutics TCT scientific 66 American Roentgen Ray 66 nd Annual Meeting 66 Liver EASL 66 ongoing Phase 1b 66 Transcatheter Cardiovascular Therapeutics 66 Arteriosclerosis Thrombosis 66 Breast Surgeons 66 Breast Cancer Symposium 65 Breast Cancer Symposium SABCS 65 Pediatric Academic Societies PAS 65 EORTC NCI AACR 65 iSBTc 65 #nd Annual Meeting 65 Vascular Annual Meeting 65 AUA Annual Meeting 65 Gastroenterology ACG Annual 65 Interventions SCAI 65 EORTC NCI AACR Symposium 65 Vascular Biology ATVB 65 Endocrine Society #nd 65 Hypertension ASH 65 Therapeutic Radiology 65 Prostate Cancer Symposium 64 Hypertension ESH 64 annual Transcatheter Cardiovascular 64 Gynecologic Cancer Society 64 Medicine SIIM 64 SCAI Annual 64 Liver Disease AASLD 64 AAN Annual Meeting 64 ECCMID 64 Gynecologic Oncologists SGO 64 Cardiovascular Anesthesiologists 64 Retina Specialists 64 AASLD 64 AACR #nd Annual Meeting 64 Anesthesiologists ASA Annual Meeting 64 ISPOR 64 GASTRO 64 Nephrology ASN Renal 64 Mass Spectrometry ASMS 64 Urology EAU 64 Endocrine Society #st 64 Malignant Lymphoma 64 SABCS 64 Annual Scientific Sessions 64 Endocrine Society Annual Meeting 63 ABRF 63 Nephrology Annual Meeting 63 Clinical Oncology ASCO 63 Stem Cell Research ISSCR 63 Anesthesiologists Annual Meeting 63 ECCO ESMO 63 League Against Rheumatism 63 Annual Transcatheter Cardiovascular 63 Minimally Invasive Cardiothoracic Surgery 63 Oncology ESTRO 63 Digestive Disease Week 63 Canaccord Adams Hepatitis C 63 #th Annual Interscience 63 International Myeloma Workshop 63 Neurology AAN 63 BCIRG 63 #nd EORTC NCI 63 Pediatric Academic Society 63 ACR ARHP 62 ACR ARHP Annual 62 Cardiology ESC 62 Spine Arthroplasty Society 62 ASCO Genitourinary Cancers Symposium 62 ESTRO 62 Lung Transplantation 62 ENDEAVOR III 62 Endovascular Therapy ISET 62 Opportunistic Infections CROI 62 European CanCer Organisation ECCO 62 ASBMR 62 International Papillomavirus 62 AACR symposium 62 Combination REOLYSIN R 62 Clinical Trials Update 62 ARVO 62 Clinical Chemistry AACC 62 IASLC 62 Atrial Fibrillation Symposium 62 Chicago Multidisciplinary Symposium 62 EFNS 62 Mineral Research ASBMR 61 BIO InvestorForum 61 USpella 61 Therapeutic Radiation Oncology 61 Hematological 61 Microbiology ASM 61 Pediatric Academic Societies 61 PreCISe 61 Nordic ACTI 61 Neurology Annual Meeting 61 Liver Diseases AASLD 61 Pharmaceutical Scientists AAPS 61 Experimental Biology EB 61 Gynecologic Oncologists 61 HFSA Annual 61 ICAAC 61 America HFSA 61 Transplantation AST 61 Maternal Fetal Medicine SMFM 61 Advanced Neuroendocrine Tumors 61 AASLD Meeting 61 AACR Meeting 61 ASTRO Annual Meeting 61 AABB Annual Meeting 61 Immunodeficiencies 61 Chemotherapy ICAAC 61 Rheumatology Annual 61 Hyperthermic Oncology ESHO 61 Molecular Targets 61 Cardiology Scientific Sessions 61 ASM Biodefense 61 Poster Discussion 60 Phase Ib study 60 SUCCEED trial 60 Thoracic Surgeons STS 60 ADA Scientific Sessions 60 Breaking Clinical Trials 60 Gynecologic Investigation 60 BIOCOM Investor Conference 60 Neoplasia 60 Abstract Accepted 60 Cardiovascular Therapeutics 60 Hygiene ASTMH 60 Annual ICAAC 60 EADV 60 CROI 60 Alzheimer Disease ICAD 60 ESMO 60 ERA EDTA 60 Diabetes EASD 60 Keystone Symposia 60 Refractive Surgery ASCRS 60 VEITHsymposium 60 EuroPCR 60 Ophthalmology ARVO 60 Echocardiography ASE 60 EASL 60 FOCIS 60 ORAL Sync 60 Hedgehog Pathway Inhibitor 60 Acute Heart Failure 60 NASDAQ SLXP today 60 Clinical Oncologists ASCO 60 Oral Presentations 60 Neck Surgery Foundation 60 Human Brain Mapping 60 CLARITY study 60 Plastic Surgeons ASPS Plastic 60 Molecular Medicine Tri 60 Cell Transplant 60 Remote Sensing ASPRS 60 Scientific Session 59 AAO HNSF Annual Meeting 59 Clinical Pathology ASCP 59 Bipolar Disorders 59 Cardiovascular Horizons 59 Symposium SABCS 59 Hsp# Inhibitor 59 Percutaneous Cardiovascular Interventions 59 EACTS 59 #rd Annual CTRC 59 Outcomes Research ISPOR 59 Gynecological Cancer 59 Cervical Pathology 59 Heart Failure Society 59 TG MV 59 Phase III ALLEGRO 59 Investigative Pathology 59 AACR Frontiers 59 Clinical Oncology 59 AACR EORTC NCI 59 Malignant Mesothelioma 59 EUROGIN 59 ARVO Annual Meeting 59 Group RTOG 59 AACR IASLC Joint 59 Applied Spectroscopy 59 Poster Presentations 59 Menopause Society NAMS 59 Breast Disease 59 Scientific Sessions 59 Anesthesiologists ASA 59 Cystic Fibrosis Conference NACFC 59 TXPO 59 Brentuximab Vedotin SGN 59 Cardiostim 59 Nephrology ASN 59 #th Interscience Conference 59 Neurological Societies 59 Cardiovascular Interventions 59 Phase Ib Clinical Trial 59 Tumor Microenvironment 59 Related Disorders ICAD 59 Lung Cancer IASLC 59 Paediatric Endocrinology 59 Neuropsychopharmacology ACNP 59 Clinical Trial Results 59 Ophthalmology ARVO Annual Meeting 59 NSTI Nanotech 59 Phase III psoriasis 59 Pirfenidone 58 Investigative Dermatology 58 Emergency Medicine SAEM 58 AACR Annual Meeting 58 Oak Brook Ill. RSNA.org 58 Phase 2a Study 58 ABCSG 58 Female Urology 58 EORTC 58 Metabolic Disorders 58 journal Antimicrobial Agents 58 BioContact Quebec 58 Gastrointestinal Oncology 58 CLEO QELS 58 NCCTG N# 58 Overactive Bladder OAB 58 Clinical Virology Symposium 58 Molecular Pathology AMP 58 Endoscopic Surgeons SAGES 58 Antiviral Research 58 Geochimica et Cosmochimica Acta 58 ASCO Gastrointestinal Cancers Symposium 58 Colposcopy 58 Oligonucleotide Therapeutics Society 58 Midyear Clinical Meeting 58 Postgraduate Course 58 Addex Pharmaceuticals SIX ADXN 58 PROactive Study 58 Inflammatory Bowel Diseases 58 Vaccine Immunology 58 th Interscience Conference 58 GTCbio 58 ISSWSH 58 Molecular Origins 58 Haemostasis ISTH 58 Medicine ISMRM 58 ASCO Prostate Cancer 58 Selective Cardiac Myosin 58 International OARSI 58 Paediatric Oncology SIOP 58 CRLX# 58 NABTT 58 Endoscopic Surgeons 58 Bariatric Surgery ASBS 58 Medicine AAPM 58 Phase #b/#a clinical 58 Chest Physicians CHEST 58 EASD 58 ACC.# 58 Nymox NX 58 Lung Transplantation ISHLT 58 Nasdaq PCYC 58 Nephrology JASN 58 Systemic Sclerosis 58 International Cartilage Repair 58 Ophthalmology AAO 58 Endovascular Therapy 58 Rheumatology Annual Meeting 58 Biologic Therapy 58 Nephrology CJASN 58 EXPAREL ™ 57 Phase Ib II 57 ECNP 57 ISTH 57 Announces Poster Presentations 57 ExTRACT TIMI 57 Photocure ASA 57 Pediatric Oncology Branch 57 FDA Oncologic Drugs 57 Antimicrobial Agents 57 Reproductive Medicine ASRM 57 CTI Nasdaq 57 Transplant Surgeons ASTS 57 Clinical Oncology JCO 57 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 57 ASCRS 57 Paediatric Infectious Diseases 57 Retrovirus Conference 57 Podium Presentation 57 Phase Ib clinical 57 Clinical Trial Data 57 Phase #/#a trial 57 SAWC WHS 57 Cardiovascular Computed Tomography 57 Oncologic 57 Chemotherapy ICAAC Infectious Diseases 57 Urology EAU Congress 57 Canaccord Genuity Growth 57 Osseointegration 57 Gynecologic Oncology Group 57 Demonstrates Sustained 57 Continence Society 57 histone deacetylase HDAC inhibitor 57 www.aacr.org 57 Gynecological Oncologists 57 CALGB 57 ASGCT 57 Otolaryngologists 57 Cardiology Heart Failure 57 RECORD1 57 CIRSE 57 Epilepsy Society 57 San Antonio Breast Cancer 57 Pediatric Otolaryngology 57 Tanespimycin 57 Gastrointestinal Endoscopy ASGE 57 Intensive Care Medicine 57 rALLy trial 57 Genta Incorporated OTCBB GETA 57 Phase III ADT 57 Liver Diseases 57 ESCRS 57 ThermoDox ® clinical 57 assessing T DM1 57 NO# [002] 57 Cancer Immunotherapy 57 Translational Oncology 57 metastatic castration resistant 57 Radiologic Technologists ASRT 57 Venereology EADV 57 Hematological Malignancies 57 AVERROES 57 Uterine Fibroid Embolization 57 BRIM2 57 Phase #/#a 57 Preclinical Data 57 Phase 1b clinical trials 57 Movement Disorder 57 Medicine SHM 57 Cardiovascular Computed Tomography SCCT 57 Marine Mammalogy 57 Wound Healing Society 57 Recurrent Chest Wall 57 MEND CABG 57 Active Biotech NASDAQ OMX 57 ENDEAVOR IV 57 CUSTOM III 57 Unither 57 Investor Luncheon 57 Nuclear Cardiology 57 abstracts summarizing 57 Experimental Biology Annual Meeting 57 World J Gastroenterol 56 randomized controlled Phase 56 Intraoperative Surgical Planning 56 Opportunistic Infections 56 Annual Interscience Conference 56 Windhover Therapeutic Area 56 Marrow Transplantation 56 Solorel TM 56 NASDAQ CXSP announced 56 Gastroenterology ACG 56 Dermatologic Surgery ASDS 56 Pharmacoeconomics 56 Cardio Thoracic Surgery 56 LD Micro 56 INSPIRE Trial Phase III 56 Ocular Inflammation 56 Urocortin 2 56 Scientific Meeting 56 PRNewswire FirstCall Tercica 56 AIR2 Trial 56 EULAR Annual 56 Aggressive Reduction 56 SYMMETRY trial 56 CIMZIA TM certolizumab pegol 56 PFO migraine 56 MOZOBIL 56 Canaccord Adams Musculoskeletal 56 EVEREST II 56 Gastrointestinal Cancer 56 Child Neurology 56 Randomized Phase II 56 Cardiovascular Intervention 56 Targeted Anticancer Therapies 56 phase IIb study 56 NASDAQ CYTK announced 56 Refractory Angina 56 Cancer Therapeutic 56 transthyretin TTR mediated amyloidosis 56 ToGA 56 Molecular Markers 56 JPMorgan SMid Cap 56 Prostate AdenoCarcinoma Treatment 56 Dr. Pingpank 56 NAREIT REITWorld 56 CALGB # [002] 56 ICON7 56 phase IIa clinical 56 Nanomedicine ASNM 56 Inflammatory Arthritis 56 PRNewswire FirstCall Genaera 56 Nasdaq INCY announced 56 Antimicrobial Chemotherapy 56 Minimally Invasive Gynecology 56 Liver Meeting 56 Clinical Microbiology 56 Amrubicin 56 AACR NCI EORTC Molecular 56 Exploration Geophysicists SEG 56 Multiple Sclerosis ECTRIMS 56 Prolongs Survival 56 Embryology ESHRE 56 AA Amyloidosis 56 Arpida Ltd. 56 Oral Fingolimod 56 BiTE R 56 Gastroenterology Nurses 56 Drug Formulation 56 BioCentury Future Leaders 56 ELACYT 56 Delcath Phase III 56 Needham Growth Stock 56 ELSO 56 CTRC AACR 56 Fifteenth Annual 56 PROSTVAC TM 56 SAEM Annual Meeting 56 Immunology Annual Meeting 56 journal Arteriosclerosis Thrombosis 56 ICR XChange Investor 56 www.asco.org 56 System Pharmacists Midyear 56 Oncologic Drugs Advisory 56 Chest Pain Centers SCPC 56 Diabetic Macular Edema DME 56 LSE ASM 56 BRIM3 56 evaluating tivozanib 56 EchoCRT 56 entitled Synergistic 56 HCV Protease Inhibitor 56 Castration Resistant Prostate Cancer 56 HCV RESPOND 2 56 Human Proteome Organization 56 J Clin Endocrinol Metab 56 ESHO 56 FOLOTYN ® 56 Phase III Clinical Trial 56 Annual Shareowner 56 perifosine KRX 56 Minimally Invasive Spine Surgery 56 Diabet Med 56 Phase 1a clinical 56 Novalis Circle 56 Nasdaq CYCC Nasdaq CYCCP 56 Integrative Oncology 56 GTCbio 3rd 56 FASEB J. 56 Prospective Multicenter 56 multicenter Phase II 56 Randomized Phase III 56 Biomolecular Sciences 56 ATVB 56 Cloretazine ® 56 Nasdaq EXAS today 56 System Pharmacists ASHP 56 ISHLT 55 COPIC Energy 55 Renal Cancer 55 II Clinical Trial 55 Endocrine Practice 55 Am J Epidemiol 55 Br J Cancer 55 brivaracetam 55 Craig Hallum Institutional Investor 55 Dr. Ayalew Tefferi 55 Personal Genomes 55 AAPS Annual Meeting 55 ENDO 55 Controlled Release 55 Anti Infective Drugs 55 Research IADR 55 ASCO 55 ASN Renal Week 55 Antiepileptic Drugs 55 Ophthalmic Drugs Advisory 55 Respiratory Society 55 Stent Thrombosis 55 COU AA 55 Circulation Cardiovascular Interventions 55 PROTECT AF 55 Arch Intern Med 55 Inc. Nasdaq VRUS 55 Neuro Oncology 55 & Immunology AAAAI 55 Therapeutic Approaches 55 Fifth Decennial International 55 Solid Tumors 55 Androxal TM 55 Toxicology SOT 55 Inc. Nasdaq IMGN 55 SPIRIT IV 55 Canaccord Genuity Healthy Living 55 HepaSphere 55 HCV SPRINT 55 BiTE antibody MT# 55 Nasdaq ONXX today 55 Retina Specialists ASRS 55 BR.# 55 AVN# Phase 55 Imaging Informatics 55 Selective Cardiac Myosin Activator 55 ASA CSSA SSSA 55 Interventional Radiological Society 55 C# BioVentures Conference 55 depsipeptide 55 Orthopedic Surgeons AAOS 55 Thoracic Surgery AATS 55 Ovarian PLCO Cancer 55 Molecular Cancer 55 Advanced Renal Cell 55 HORIZONS AMI 55 PERSEUS clinical program 55 ACUITY trial 55 Cardiovascular Disease Epidemiology 55 Edge STudy 55 preclinical pharmacokinetic 55 recurrent malignant glioma 55 Pivotal Clinical Trial 55 Phase 2b Clinical Trial 55 Printable slides 55 NASDAQ PCYC 55 Lysosomal Disease Network 55 randomized Phase III 55 Rheumatology ACR 55 J Clin Oncol 55 Chronic Lymphocytic Leukemia CLL 55 pharmacokinetic PK 55 Annual Meeting 55 Anaesthesiologists 55 developer Antisoma plc 55 APEX AMI trial 55 Vascular Surgery SVS 55 IMPAKT Breast Cancer 55 NASDAQ ARRY 55 ENESTnd 55 Hormone Refractory Prostate Cancer 55 Adult Stem Cell Therapy 55 prospective multicentre 55 Arch Surg 55 Breast Brachytherapy 55 AIDAC 55 NAREIT Investor 55 Antibody Therapeutics 55 agalsidase alfa 55 Chemophase 55 Ocrelizumab 55 ASMS Conference 55 Therapeutic Advances 55 Gastric Cancer 55 AAPM 55 Ocular Pharmacology 55 oral FTY# 55 phase 2a 55 Aesthetic Mesotherapy 55 PEG SN# 55 Allergology 55 Hematology 55 Cytopathology 55 Radiation Therapy Oncology 55 American Psychosomatic Society 55 & OTO EXPO 55 RNAi Therapeutic 55 LUMINATE 55 MYTHOS trial 55 PROTECT II 55 SMT C# 55 mitogen activated ERK kinase 55 National Oncologic PET 55 SPIRIT FIRST 55 Diabetologia 55 Proc Am Soc 55 ASHG 55 PERSEUS 55 Acute Decompensated Heart Failure 55 Cambridge Healthtech Institute 55 Perinatal Epidemiology 55 Neurological Surgeons CNS 55 Acute MI 55 Preclinical Study 55 Randomized Phase 55 DIA EuroMeeting 55 Dermatology Physician Assistants 55 SIX ATLN 55 Needham Biotechnology 55 Neurological Societies EFNS 55 Arch Neurol 55 NSABP B 55 Phase III AFFIRM 55 Transcatheter 55 Thoracic Oncology 55 fosbretabulin 54 Canaccord Adams Healthy Living 54 Therapeutic Targets 54 Rheumatology EULAR 54 Physiological Society 54 Outpatient Setting 54 Therapeutics Roundtable 54 Macula Society 54 Photovoltaics Summit 54 Interscience Conference 54 olaparib 54 Biological Effects 54 Poster Presentation 54 INCB# [001] 54 Phase 1b trial 54 Biotherapy 54 Healthcare Publication Editors 54 DASISION 54 number NCT# ClinicalTrials.gov 54 Heart Assn 54 Growth Institutional Investor 54 NCIC CTG 54 phase IIb clinical 54 Metastatic Melanoma 54 IL# PE#QQR 54 genitourinary cancers 54 Inc. Nasdaq ANDS 54 Immunologists 54 CombAT 54 Cimzia ® certolizumab pegol 54 Biodetection Technologies 54 Neurological Surgeons AANS 54 RECIST Response Evaluation Criteria 54 ACM SIGCOMM 54 HIMSS Healthcare 54 Exon Skipping 54 SOUTHWESTERN SHOWCASE Investor 54 Liver Disease 54 CARE HF 54 lexidronam injection 54 Anticancer Drug 54 SPIE Photonics West 54 Coronary Revascularization 54 Geriatric Oncology 54 Agennix AG FRANKFURT AGX 54 recurrent GBM 54 CR# vcMMAE 54 PRNewswire FirstCall Genta Incorporated 54 Minimally Invasive Therapy 54 Pulmonary Arterial Hypertension 54 BioPartnering Europe 54 Nexavar sorafenib 54 trastuzumab DM1 T DM1 54 TASKi2 54 Immunotherapeutic 54 Cardiovascular Renal Physiology 54 #-#,# [015] 54 TEMSO 54 CAMMS# 54 huC# DM4 54 Experimental Hematology 54 Phase 2a trial 54 Genitourinary Cancer 54 CHAMPION PCI 54 Heska Announces 54 journal Catheterization 54 ThinkEquity Partners Growth 54 Abstract Number 54 ThinkEquity Growth 54 Inc. Nasdaq AVRX 54 Brachytherapy Society 54 AAEP Convention 54 Phase 2b RESTORE CLI 54 Interventional Oncology 54 Diabetic Macular Edema 54 CRMD# 54 Other OTC BVTI 54 Two Investor Conferences 54 Phase III VISTA 54 HYVET 54 Artificial Organs 54 multicenter placebo controlled 54 Annual AIFA 54 Digital Mammographic Imaging 54 Neuropathic Pain 54 www.rxipharma.com 54 GENASIS 54 PCI ExTRACT TIMI 54 BHIVA 54 Inc. NASDAQ HEPH 54 Nasdaq REGN 54 Neuropsychopharmacology 54 Heart Rhythm 54 Initiates Phase III 54 Phase 2a clinical 54 Breaking Clinical Trial 54 Clinical Dermatology 54 prospective multicenter study 54 Centers NCBC 54 Genital Infection 54 RESTORE CLI 54 IEEE CPMT 54 Targeted Therapies 54 Br J Haematol 54 CLARITY TIMI 54 Tesmilifene 54 Cardiology ACC 54 Preventive Oncology 54 America RSNA 54 TACI Ig 54 Canaccord Genuity Musculoskeletal 54 HDL Selective Delipidation 54 Radiology ECR 54 Glufosfamide 54 Kongresshaus 54 ANN INTERN MED 54 Islet Transplant 54 ThermoDox R 54 CEQ# 54 Severe Sepsis 54 CTAP# Capsules 54 Endourology 54 Orqis Medical 54 Pacifico Yokohama Japan 54 Announces Rescheduling 54 EFORT Congress 54 phase IIb trial 54 Inc. Nasdaq OPTR 54 AGBT 54 randomized discontinuation trial 54 ASMBS 54 American Thoracic Society 54 Nasdaq IMGN 54 DDW ® 54 JMP Securities Healthcare 54 MERIT ES 54 Planet xMAP Europe 54 Hand ASSH 54 Presents Positive 54 Novel Therapeutics 54 fidaxomicin Phase 3 54 Martinsried Munich 54 Cinapsys Microcap Conference 54 rALLy clinical trial 54 novel VDA molecule 54 vascular disrupting agent 54 MTT S 54 Ultrafast Insulin 53 Two Upcoming Investor 53 evaluating REVLIMID 53 SIMposium 53 LibiGel ® 53 Cardiovascular Angiography 53 Diabetes EASD Annual Meeting 53 evaluating mipomersen 53 alvespimycin 53 bazedoxifene conjugated estrogens 53 Whistler Institutional Investor 53 NAREIT REITWeek 53 International Neuropsychological Society 53 Clinical Virology 53 TTF Therapy 53 Phase 2b kidney transplant 53 Preclinical Models 53 huN# DM1 53 Screening Trial 53 Cancer Immunology Immunotherapy 53 Randomized Clinical Trial 53 comparing alemtuzumab 53 Telik Announces 53 EURIDIS 53 ASCO abstract 53 Pulmonary Hypertension 53 phase IIa 53 www.pranabio.com 53 APPRAISE 53 Histocompatibility 53 Myelodysplastic Syndromes 53 PROVENGE sipuleucel T 53 ZYBRESTAT 53 Carotid Revascularization Endarterectomy vs. 53 ® DDW 53 Diabetic Foot 53 J Natl Cancer Inst 53 BioNumerik 53 See CLINICAL PHARMACOLOGY 53 NASDAQ LIPD 53 Demonstrate Significant 53 Lancet Oncol 53 relapsed MM 53 Urologic Oncology 53 Neonatal Nurses 53 preclinical efficacy 53 Inc. Nasdaq AMLN 53 ALN TTR 53 multicenter randomized Phase 53 Inc. NASDAQ SGEN 53 Drugs Affecting Lipid 53 Myeloproliferative Disorders 53 Lupus Nephritis 53 Prostate Disease 53 Vascugel 53 Cochrane Hepato Biliary 53 Inc. Nasdaq ARQL 53 Addiction Medicine ASAM 53 Myeloproliferative Neoplasms 53 Initiates Enrollment 53 Melanoma XII 53 Dr. Gulfo 53 HyQ 53 Complete Remission 53 J Thorac Cardiovasc Surg 53 Spine Society 53 Infectious Diseases ECCMID 53 Stenting Trial CREST 53 NYSE Amex RGN 53 recurrent glioma 53 anticancer compound 53 YONDELIS 53 EOquin TM 53 vismodegib 53 #th Annual Retrovirus 53 Thomas Weisel Partners Tech# 53 Nuclear Cardiology ASNC 53 including eniluracil ADH 53 journal Menopause 53 UZ Brussel 53 Association EHA 53 J.P. Morgan Healthcare 53 EMBO J. 53 HER2 positive metastatic breast 53 CT Colonography Trial 53 Zenvia Phase III 53 SWX RO SWX ROG 53 Genome Biology 53 Circulation Heart Failure 53 Veterinary Dental 53 Phase 2a 53 Prospective Randomized 53 • cbleich@news-press.com • 53 Surgeons ACS 53 Hematologic Malignancies 53 Ambulatory Pediatrics 53 Romidepsin 53 • jtemple@muncie.gannett.com • 53 cetuximab Erbitux 53 Alzhemed TM 53 AVADO 53 Gastroenterology Week UEGW 53 Acute Ischemic Stroke 53 ALLSCHWIL BASEL SWITZERLAND 53 Environ Health Perspect 53 SPIRIT III 53 Lehman Brothers T4 53 Electro Optics CLEO 53 Preclinical Efficacy 53 Oncology Nursing 53 Association Executives ASAE 53 Radiation Oncologists 53 RIO Lipids 53 Interventional Radiology 53 PEGylated interferon beta 1a 53 MGd 53 Nasdaq ALXN 53 coronary stent merged 53 oral ridaforolimus 53 Phase IIB clinical 53 ASNR 53 PRNewswire FirstCall Kensey Nash 53 axitinib 53 Antiviral Drugs Advisory 53 multicenter randomized controlled 53 multicenter Phase 53 Ann Intern Med 53 Endoscopic Surgery 53 Phase 2a Trial 53 Nicotine Vaccine 53 Medicinal Chemistry Letters 53 Heart Failure Patients 53 Annual Gala Dinner 53 BY VALERIE GIBBONS 53 Inc. NASDAQ NBIX 53 Inc. NASDAQ ACUS 53 Echocardiographic 53 Neck Cancer 53 Urologic Nursing 53 GVAX ® 53 MelaFind pivotal 53 MERLIN TIMI 53 Interventional Radiologists 53 abstr 53 CLL8 53 TORISEL TM 53 Bariatric Surgeons 53 Completes Patient Enrollment 53 seliciclib CYC# 53 Chronic Lymphocytic Leukemia 53 Metabolic Endocrinology 53 Cachexia 53 Thoracic Surgeons 53 • njobst@dmreg.com • 53 dose escalation clinical 53 IEEE Electron Devices 53 delafloxacin 53 EuroIntervention 53 HORIZONS AMI trial 53 Val HeFT 53 MorphoSys AG FSE MOR 53 Biomacromolecules 53 Annual BioPartnering Europe 53 liposome injection 53 visceral metastases 53 Neuromuscular Diseases 53 Hepatocellular Carcinoma 53 Gaylord Palms Hotel 53 AAGL 53 Natalizumab 53 Personalized Immunotherapy 53 By JENNIFER LEARN 53 Deforolimus 53 Radiology Imaging Network ACRIN 53 www.nejm.org 53 ADVANCE PD 53 Biomolecular Sciences SBS 53 forodesine 53 Immunomedics Announces 53 Keystone Symposium 53 taxane resistant 53 Reconvened 53 multicenter Phase III 53 ACR# responses 53 evaluating satraplatin 53 HUPO 53 Retroviruses 53 frajkowski@stcloudtimes.com • 53 Ambulatory Anesthesia 53 Vacuum Coaters 53 Pivotal Trial 53 KRN# 53 Dr. Goldknopf 53 Acute Renal Failure 53 Innate Immunity 53 Translational Regenerative Medicine 53 Inc. Nasdaq ULGX 53 BioEquity Europe